LIGAND PHARMACEUTICALS INCORPORATED Increase (Decrease) in Other Operating Assets and Liabilities, Net
LIGAND PHARMACEUTICALS INCORPORATED (LGNDZ) reported Increase (Decrease) in Other Operating Assets and Liabilities, Net of -$980.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet · last filed 2026-08-07
- LIGAND PHARMACEUTICALS INCORPORATED increase (decrease) in other operating assets and liabilities, net for the quarter ending 2026-06-30 was -$773.00K, a 118.14% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED increase (decrease) in other operating assets and liabilities, net for the quarter ending 2026-03-31 was -$207.00K, a 110.43% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED increase (decrease) in other operating assets and liabilities, net for the quarter ending 2025-12-31 was -$2.21M.
- LIGAND PHARMACEUTICALS INCORPORATED increase (decrease) in other operating assets and liabilities, net for the quarter ending 2025-09-30 was -$148.00K.
- LIGAND PHARMACEUTICALS INCORPORATED increase (decrease) in other operating assets and liabilities, net for fiscal 2025 was $3.89M.
- LIGAND PHARMACEUTICALS INCORPORATED increase (decrease) in other operating assets and liabilities, net for fiscal 2024 was -$1.29M, a 113.09% decline from fiscal 2023.
- LIGAND PHARMACEUTICALS INCORPORATED increase (decrease) in other operating assets and liabilities, net for fiscal 2023 was $9.87M.
- LIGAND PHARMACEUTICALS INCORPORATED increase (decrease) in other operating assets and liabilities, net for fiscal 2022 was -$6.34M, a 171.06% decline from fiscal 2021.
| Period end | Increase (Decrease) in Other Operating Assets and Liabilities, Net 3 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 3 month as first filed | Increase (Decrease) in Other Operating Assets and Liabilities, Net 6 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 6 month as first filed | Increase (Decrease) in Other Operating Assets and Liabilities, Net 9 month | Increase (Decrease) in Other Operating Assets and Liabilities, Net 9 month as first filed | Increase (Decrease) in Other Operating Assets and Liabilities, Net 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$773.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$980.00K 10-Q · filed 2026-08-07 | -$3.19M derived: sum of 3 quarters · filed 2026-08-07 | -$3.34M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2026-03-31 | -$207.00K 10-Q · filed 2026-05-08 | -$2.42M derived: sum of 2 quarters · filed 2026-05-08 | -$2.57M derived: sum of 3 quarters · filed 2026-05-08 | $1.70M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-12-31 | -$2.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$2.36M derived: sum of 2 quarters · filed 2026-02-27 | $1.90M derived: sum of 3 quarters · filed 2026-08-07 | $3.89M 10-K · filed 2026-02-27 | |||
| 2025-09-30 | -$148.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $4.11M derived: sum of 2 quarters · filed 2026-08-07 | $6.10M 10-Q · filed 2025-11-07 | $5.46M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-06-30 | $4.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $6.25M 10-Q · filed 2026-08-07 | $5.61M derived: sum of 3 quarters · filed 2026-08-07 | -$1.88M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-03-31 | $1.99M 10-Q · filed 2026-05-08 | $1.35M derived: sum of 2 quarters · filed 2026-05-08 | -$6.14M derived: sum of 3 quarters · filed 2026-05-08 | -$2.77M derived: sum of 4 quarters · filed 2026-05-08 | |||
| 2024-12-31 | -$634.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$8.13M derived: sum of 2 quarters · filed 2026-02-27 | -$4.75M derived: sum of 3 quarters · filed 2026-02-27 | -$1.29M 10-K · filed 2026-02-27 | |||
| 2024-09-30 | -$7.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$4.12M derived: sum of 2 quarters · filed 2025-11-07 | -$657.00K 10-Q · filed 2025-11-07 | $9.23M derived: sum of 4 quarters · filed 2026-02-27 | |||
| 2024-06-30 | $3.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $6.84M 10-Q · filed 2025-08-08 | $16.72M derived: sum of 3 quarters · filed 2026-02-27 | $16.58M derived: sum of 4 quarters · filed 2026-02-27 | |||
| 2024-03-31 | $3.46M 10-Q · filed 2025-05-09 | $13.35M derived: sum of 2 quarters · filed 2026-02-27 | $13.20M derived: sum of 3 quarters · filed 2026-02-27 | $14.01M derived: sum of 4 quarters · filed 2026-02-27 | |||
| 2023-12-31 | $9.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $9.74M derived: sum of 2 quarters · filed 2026-02-27 | $10.55M derived: sum of 3 quarters · filed 2026-02-27 | $9.87M 10-K · filed 2026-02-27 | |||
| 2023-09-30 | -$144.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $663.00K derived: sum of 2 quarters · filed 2024-11-08 | -$19.00K 10-Q · filed 2024-11-08 | $899.00K 10-Q · filed 2023-11-09 | -$8.02M derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2023-06-30 | $807.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $125.00K 10-Q · filed 2024-08-07 | $130.00K 10-Q · filed 2023-08-09 | -$7.87M derived: sum of 3 quarters · filed 2025-02-28 | -$9.72M derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2023-03-31 | -$682.00K 10-Q · filed 2024-05-08 | -$8.68M derived: sum of 2 quarters · filed 2025-02-28 | -$10.53M derived: sum of 3 quarters · filed 2025-02-28 | -$8.75M derived: sum of 4 quarters · filed 2025-02-28 | |||
| 2022-12-31 | -$8.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$9.85M derived: sum of 2 quarters · filed 2025-02-28 | -$8.06M derived: sum of 3 quarters · filed 2025-02-28 | -$6.34M 10-K · filed 2025-02-28 | |||
| 2022-09-30 | -$1.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$69.00K derived: sum of 2 quarters · filed 2023-11-09 | $1.65M 10-Q · filed 2023-11-09 | $1.67M 10-Q · filed 2022-11-08 | $4.67M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-06-30 | $1.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $3.51M 10-Q · filed 2023-08-09 | $1.25M 10-Q · filed 2022-08-09 | $6.52M derived: sum of 3 quarters · filed 2024-02-29 | $7.53M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-03-31 | $1.72M 10-Q · filed 2023-05-08 | $233.00K 10-Q · filed 2022-05-09 | $4.74M derived: sum of 2 quarters · filed 2024-02-29 | $5.75M derived: sum of 3 quarters · filed 2024-02-29 | $6.88M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2021-12-31 | $3.02M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $4.03M derived: sum of 2 quarters · filed 2024-02-29 | $5.16M derived: sum of 3 quarters · filed 2024-02-29 | $8.93M 10-K · filed 2024-02-29 | |||
| 2021-09-30 | $1.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $2.14M derived: sum of 2 quarters · filed 2022-11-08 | $5.91M 10-Q · filed 2022-11-08 | $8.68M 10-Q · filed 2021-11-09 | $6.20M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-06-30 | $1.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $4.90M 10-Q · filed 2022-08-09 | $2.79M 10-Q · filed 2021-08-03 | $5.19M derived: sum of 3 quarters · filed 2023-02-28 | $5.72M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-03-31 | $3.77M 10-Q · filed 2022-05-09 | $4.06M derived: sum of 2 quarters · filed 2023-02-28 | $4.59M derived: sum of 3 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | $292.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $820.00K derived: sum of 2 quarters · filed 2023-02-28 | $4.95M 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | $528.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $4.66M 10-Q · filed 2021-11-09 | |||||
| 2020-06-30 | $4.13M 10-Q · filed 2021-08-03 | ||||||
| 2018-03-31 | $522.00K 10-Q · filed 2018-05-09 | ||||||
| 2017-03-31 | -$633.00K 10-Q · filed 2018-05-09 |